You're currently on:

The Ethics of Postmarketing Observational Studies of Drug Safety Under Section 505(o)(3) of the Food, Drug, and Cosmetic Act

Double click on above image to view full picture

Zoom Out
Zoom In

More Views

The Ethics of Postmarketing Observational Studies of Drug Safety Under Section 505(o)(3) of the Food, Drug, and Cosmetic Act

Availability: In stock.

$20.00
Add Items to Cart
The Ethics of Postmarketing Observational Studies of Drug Safety Under Section 505(o)(3) of the Food, Drug, and Cosmetic Act

Description

The Ethics of Postmarketing Observational Studies of Drug Safety Under Section 505(o)(3) of the Food, Drug, and Cosmetic Act

Additional Information

Author Barbara J. Evans
Number 4
Volume 38
Publication AJLM
Journal Year 2012
 

My Cart

You have no items in your shopping cart.